Peptidylglycine α-amidating monooxygenase and adrenomedullin measurement in patients with hepatic cirrhosis

Novel insights into peptide amidation and amidating activity in the human circulation

(2021) Paul Kaufmann et al.   Scientific Reports

Dipeptidyl peptidase-3 is associated with severity of liver disease and circulatory complications in patients with cirrhosis

(2021) Andrei Mihai Voiosu et al.   BIOMARKERS

Bioactive adrenomedullin in plasma is associated with biventricular filling pressures in patients with advanced heart failure

(2020) Jens P. Goetze et al.   EUROPEAN JOURNAL OF HEART FAILURE

Peptidylglycine α-amidating monooxygenase is required for atrial secretory granule formation

(2020) Nils Bäck et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

An update on cirrhotic cardiomyopathy

(2019) Søren Møller et al.   Expert Review of Gastroenterology & Hepatology

Adrenomedullin in heart failure: pathophysiology and therapeutic application

(2018) Adriaan A. Voors et al.   EUROPEAN JOURNAL OF HEART FAILURE

Biomarkers and immunoassay kits: a matter of growing concern

(2015) Jens F Rehfeld et al.   Biomarkers in Medicine

New vasoactive peptides in cirrhosis: organ extraction and relation to the vasodilatory state

(2014) Nina Kimer et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION